3F7Z image
Deposition Date 2008-11-10
Release Date 2009-03-10
Last Version Date 2024-11-27
Entry Detail
PDB ID:
3F7Z
Keywords:
TRANSFERASE
Title:
X-ray Co-Crystal Structure of Glycogen Synthase Kinase 3beta in Complex with an Inhibitor
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Spodoptera frugiperda
Method Details:
Experimental Method:
X-RAY DIFFRACTION
Resolution:
2.40 Å
R-Value Free:
0.25
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
P 1 21 1
3F7Z validation report
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Glycogen synthase kinase-3 beta
Gene (Uniprot):GSK3B
Chain IDs:A, B
Chain Length:350
Number of Molecules:2
Biological Source:Homo sapiens
UniProt ID:P49841 Pfam ID:PF00069 EC:2.7.11.26
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
PTR A TYR O-PHOSPHOTYROSINE
Ligand Molecules
34O
Primary Citation
Design, synthesis and structure-activity relationships of 1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3beta.
Bioorg.Med.Chem. 17 2017 2029 (2009)
PMID: 19200745 DOI: 10.1016/j.bmc.2009.01.019

Abstact

Glycogen synthase kinase-3beta (GSK-3beta) is implicated in abnormal hyperphosphorylation of tau protein and its inhibitors are expected to be a promising therapeutic agents for the treatment of Alzheimer's disease. Here we report design, synthesis and structure-activity relationships of a novel series of oxadiazole derivatives as GSK-3beta inhibitors. Among these inhibitors, compound 20x showed highly selective and potent GSK-3beta inhibitory activity in vitro and its binding mode was determined by obtaining the X-ray co-crystal structure of 20x and GSK-3beta.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
3F7Z
Feedback Form
Name
Email
Institute
Feedback